COVID-19 and Pneumolysis Simulating Extreme High-altitude Exposure with Altered Oxygen Transport Physiology; Multiple Diseases, and Scarce Need of Ventilators: Andean Condor's-eye-view.

dc.contributor.authorZubieta-Calleja, Gustavo
dc.contributor.authorZubieta-DeUrioste, Natalia
dc.contributor.authorVenkatesh, Thuppil
dc.contributor.authorDas, Kusal K
dc.contributor.authorSoliz, Jorge
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-24T15:04:26Z
dc.date.available2026-03-24T15:04:26Z
dc.date.issued2020
dc.descriptionVol. 15, No. 4, pp. 347-359
dc.description.abstractBACKGROUND: Critical hypoxia in this COVID-19 pandemic results in high mortality and economic loss worldwide. Initially, this disease' pathophysiology was poorly understood and interpreted as a SARS (Severe Acute Respiratory Syndrome) pneumonia. The severe atypical lung CAT scan images alerted all countries, including the poorest, to purchase lacking sophisticated ventilators. However, up to 88% of the patients on ventilators lost their lives. It was suggested that COVID-19 could be similar to a High-Altitude Pulmonary Edema (HAPE). New observations and pathological findings are gradually clarifying the disease. METHODS: As high-altitude medicine and hypoxia physiology specialists working and living in the highlands for over 50 years, we perform a perspective analysis of hypoxic diseases treated at high altitudes and compare them to Covid-19. Oxygen transport physiology, SARS-Cov-2 characteristics, and its transmission, lung imaging in COVID-19, and HAPE, as well as the causes of clinical signs and symptoms, are discussed. RESULTS: High-altitude oxygen transport physiology has been systematically ignored. COVID-19 signs and symptoms indicate a progressive and irreversible failure in the oxygen transport system, secondary to pneumolysis produced by SARS-Cov-2's alveolar-capillary membrane "attack". HAPE's pulmonary compromise is treatable and reversible. COVID-19 is associated with several diseases, with different individual outcomes, in different countries, and at different altitudes. CONCLUSIONS: The pathophysiology of High-altitude illnesses can help explain COVID-19 pathophysiology, severity, and management. Early diagnosis and use of EPO, acetylsalicylic-acid, and other anti-inflammatories, oxygen therapy, antitussives, antibiotics, and the use of Earth open-circuit- astronaut-resembling suits to return to daily activities, should all be considered. Ventilator use can be counterproductive. Immunity development is the only feasible long-term survival tool.eng
dc.description.sponsorshipHigh Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana - Prolongacion # 55, La Paz, Bolivia. | High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana - Prolongacion # 55, La Paz, Bolivia. | High Altitude Pulmonary and Pathology Institute (HAPPI-IPPA), Av. Copacabana - Prolongacion # 55, La Paz, Bolivia.
dc.identifier.doi10.2174/1574887115666200925141108
dc.identifier.issn1876-1038
dc.identifier.otherPMID:32981508
dc.identifier.urihttps://doi.org/10.2174/1574887115666200925141108
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/101044
dc.language.isoeng
dc.relation.ispartofReviews on recent clinical trials
dc.sourcePubMed
dc.subjectEPO
dc.subjectHAPE
dc.subjectPolyerythrocythemia
dc.subjectSARS-Cov-2
dc.subjectcoronavirus suit
dc.subjecttolerance to hypoxia
dc.titleCOVID-19 and Pneumolysis Simulating Extreme High-altitude Exposure with Altered Oxygen Transport Physiology; Multiple Diseases, and Scarce Need of Ventilators: Andean Condor's-eye-view.
dc.typeArtículo Científico Publicado

Files